News

Rhythm Pharmaceuticals, Inc. (RYTM) on Wednesday announced that its drug Bivamelagon achieved statistically significant and ...
A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...
Rhythm Pharmaceuticals' experimental drug helped patients with a rare form of obesity caused by brain damage cut weight in a small study, the drugmaker said on Monday, sending its shares 24% higher in ...
A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging.
MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...
Regeneron Pharmaceuticals has received accelerated FDA approval for Lynozyfic, a new bispecific antibody treatment for adults with relapsed or refractory multiple myeloma who have undergone at least ...